{"id":"https://openalex.org/W7214906056","doi":"https://doi.org/10.7759/cureus.117185","title":"Baseline Optical Coherence Tomography Features and Visual Outcomes After Anti-vascular Endothelial Growth Factor Therapy for Retinal Vein Occlusion-Associated Macular Edema: A Prospective Observational Study","display_name":"Baseline Optical Coherence Tomography Features and Visual Outcomes After Anti-vascular Endothelial Growth Factor Therapy for Retinal Vein Occlusion-Associated Macular Edema: A Prospective Observational Study","publication_year":2026,"publication_date":"2026-09-29","ids":{"openalex":"https://openalex.org/W7214906056","doi":"https://doi.org/10.7759/cureus.117185","pmid":"https://pubmed.ncbi.nlm.nih.gov/42964585","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13720275"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117185","doi":"https://doi.org/10.7759/cureus.117185","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117185","pdf_url":"https://www.cureus.com/articles/535583-baseline-optical-coherence-tomography-features-and-visual-outcomes-after-anti-vascular-endothelial-growth-factor-therapy-for-retinal-vein-occlusion-associated-macular-edema-a-prospective-observational-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/535583-baseline-optical-coherence-tomography-features-and-visual-outcomes-after-anti-vascular-endothelial-growth-factor-therapy-for-retinal-vein-occlusion-associated-macular-edema-a-prospective-observational-study.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122814375","display_name":"Garima Mandloi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151372","display_name":"Gandhi Medical College","ror":"https://ror.org/04npss011","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210151372"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Garima Mandloi","raw_affiliation_strings":["Ophthalmology, Gandhi Medical College, Bhopal, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Gandhi Medical College, Bhopal, IND","institution_ids":["https://openalex.org/I4210151372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153580695","display_name":"Ekta Thakur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151372","display_name":"Gandhi Medical College","ror":"https://ror.org/04npss011","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210151372"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ekta Thakur","raw_affiliation_strings":["Ophthalmology, Gandhi Medical College, Bhopal, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Gandhi Medical College, Bhopal, IND","institution_ids":["https://openalex.org/I4210151372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121195716","display_name":"Anshul Tiwari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151372","display_name":"Gandhi Medical College","ror":"https://ror.org/04npss011","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210151372"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anshul Tiwari","raw_affiliation_strings":["Ophthalmology, Gandhi Medical College, Bhopal, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Gandhi Medical College, Bhopal, IND","institution_ids":["https://openalex.org/I4210151372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153563820","display_name":"Sneha Alaway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151372","display_name":"Gandhi Medical College","ror":"https://ror.org/04npss011","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210151372"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sneha Alaway","raw_affiliation_strings":["Ophthalmology, Gandhi Medical College, Bhopal, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Gandhi Medical College, Bhopal, IND","institution_ids":["https://openalex.org/I4210151372"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5153617567","display_name":"Ahtesham Ansari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ahtesham Ansari","raw_affiliation_strings":["Ophthalmology, Civil Hospital Sihora, Jabalpur, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Civil Hospital Sihora, Jabalpur, IND","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5153617567"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.67175359,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"9","first_page":"e117185","last_page":"e117185"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinal-vein-occlusion","display_name":"retinal vein occlusion","score":0.9850000143051147},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.9580000042915344},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.7260000109672546},{"id":"https://openalex.org/keywords/optical-coherence-tomography-features","display_name":"optical coherence tomography features","score":0.890999972820282},{"id":"https://openalex.org/keywords/visual-acuity-outcomes","display_name":"visual acuity outcomes","score":0.7670000195503235},{"id":"https://openalex.org/keywords/central-macular-thickness","display_name":"central macular thickness","score":0.9539999961853027},{"id":"https://openalex.org/keywords/macular-volume","display_name":"macular volume","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ellipsoid-zone-disruption","display_name":"ellipsoid zone disruption","score":0.8799999952316284},{"id":"https://openalex.org/keywords/external-limiting-membrane-disruption","display_name":"external limiting membrane disruption","score":0.8309999704360962},{"id":"https://openalex.org/keywords/disorganization-of-retinal-inner-layers","display_name":"disorganization of retinal inner layers","score":0.8560000061988831},{"id":"https://openalex.org/keywords/branch-retinal-vein-occlusion","display_name":"branch retinal vein occlusion","score":0.871999979019165},{"id":"https://openalex.org/keywords/ischemic-retinal-vein-occlusion","display_name":"ischemic retinal vein occlusion","score":0.8069999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.978600025177002},{"id":"https://openalex.org/C2778818243","wikidata":"https://www.wikidata.org/wiki/Q899552","display_name":"Optical coherence tomography","level":2,"score":0.7907999753952026},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7300999760627747},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.567799985408783},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.5040000081062317},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.49320000410079956},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.487199991941452},{"id":"https://openalex.org/C2908732032","wikidata":"https://www.wikidata.org/wiki/Q5062148","display_name":"Retinal Vein","level":3,"score":0.4503999948501587},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4431000053882599},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.3630000054836273},{"id":"https://openalex.org/C12725497","wikidata":"https://www.wikidata.org/wiki/Q810247","display_name":"Baseline (sea)","level":2,"score":0.3515999913215637},{"id":"https://openalex.org/C2780248432","wikidata":"https://www.wikidata.org/wiki/Q1434206","display_name":"Fluorescein angiography","level":3,"score":0.33880001306533813},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.3122999966144562},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.3012999892234802},{"id":"https://openalex.org/C163716698","wikidata":"https://www.wikidata.org/wiki/Q841267","display_name":"Tomography","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.2639999985694885},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.2515999972820282}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.117185","doi":"https://doi.org/10.7759/cureus.117185","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117185","pdf_url":"https://www.cureus.com/articles/535583-baseline-optical-coherence-tomography-features-and-visual-outcomes-after-anti-vascular-endothelial-growth-factor-therapy-for-retinal-vein-occlusion-associated-macular-edema-a-prospective-observational-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13720275","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13720275/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13720275/pdf/cureus-0018-00000117185.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:42964585","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42964585","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.117185","doi":"https://doi.org/10.7759/cureus.117185","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117185","pdf_url":"https://www.cureus.com/articles/535583-baseline-optical-coherence-tomography-features-and-visual-outcomes-after-anti-vascular-endothelial-growth-factor-therapy-for-retinal-vein-occlusion-associated-macular-edema-a-prospective-observational-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214906056.pdf","grobid_xml":"https://content.openalex.org/works/W7214906056.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W2895748115","https://openalex.org/W2898007984","https://openalex.org/W2971167736","https://openalex.org/W3131125541","https://openalex.org/W3214799000","https://openalex.org/W4200556591","https://openalex.org/W4205243730","https://openalex.org/W4210944984","https://openalex.org/W4280588746","https://openalex.org/W4283716359","https://openalex.org/W4302305016","https://openalex.org/W4311581672","https://openalex.org/W4365811185","https://openalex.org/W4412902675"],"related_works":["https://openalex.org/W4360601249","https://openalex.org/W2613397178","https://openalex.org/W4391107109","https://openalex.org/W4229008451","https://openalex.org/W4396747956","https://openalex.org/W3092983131","https://openalex.org/W4402964551","https://openalex.org/W2417634952","https://openalex.org/W3131125541","https://openalex.org/W2931710213"],"abstract_inverted_index":{"Background":[0],"Macular":[1],"edema":[2,89],"is":[3],"a":[4,54],"major":[5],"cause":[6],"of":[7,82,120,146],"visual":[8,25,44,118,181,260,274],"loss":[9],"in":[10,184,217],"retinal":[11,23,148],"vein":[12],"occlusion":[13],"(RVO).":[14],"Although":[15],"anti-vascular":[16],"endothelial":[17],"growth":[18],"factor":[19],"(anti-VEGF)":[20],"therapy":[21],"reduces":[22],"thickening,":[24],"recovery":[26],"varies.":[27],"The":[28],"primary":[29],"objective":[30],"was":[31,71,114,243,256,279],"to":[32],"assess":[33],"whether":[34],"baseline":[35,226,267],"optical":[36],"coherence":[37],"tomography":[38],"(OCT)":[39],"features":[40,126,269],"were":[41,163,195,215,235,270],"associated":[42,196,236,244,258,271],"with":[43,85,104,197,237,245,259,272,297],"acuity":[45,119],"one":[46,106],"month":[47,107],"after":[48,108],"the":[49,147,176,218],"third":[50],"anti-VEGF":[51,102],"injection":[52],"using":[53,165,175],"prespecified":[55],"6/18":[56,121],"threshold.":[57],"Secondary":[58],"objectives":[59],"assessed":[60],"demographic":[61],"and":[62,94,139,154,172,192,206,212,232,285,302],"clinical":[63,293],"associations,":[64],"while":[65],"central":[66],"macular":[67,88,129,134,227],"thickness":[68],"(CMT)":[69],"reduction":[70,253,278],"evaluated":[72],"exploratorily.":[73],"Methodology":[74],"This":[75],"prospective":[76],"observational":[77],"study":[78],"included":[79,127],"60":[80,83],"eyes":[81],"patients":[84],"center-involving,":[86],"RVO-associated":[87],"treated":[90],"between":[91],"September":[92],"2022":[93],"February":[95],"2024.":[96],"Each":[97],"eye":[98],"received":[99],"three":[100],"intravitreal":[101],"injections,":[103],"assessment":[105],"each":[109],"injection.":[110],"A":[111],"good":[112,198,246],"outcome":[113,182,261],"defined":[115],"as":[116],"final":[117,213,273],"or":[122,168,292],"better.":[123],"Baseline":[124,211],"OCT":[125,268],"CMT,":[128],"volume,":[130,228],"hyperreflective":[131],"foci,":[132],"serous":[133],"detachment,":[135],"ellipsoid":[136],"zone":[137],"(EZ)":[138],"external":[140,303],"limiting":[141],"membrane":[142],"(ELM)":[143],"integrity,":[144],"disorganization":[145],"inner":[149],"layers":[150],"(DRIL),":[151],"foveal":[152,241],"bulge,":[153],"ganglion":[155],"cell":[156],"layer":[157],"(GCL)":[158],"cystic":[159],"spaces.":[160],"Categorical":[161],"variables":[162,174],"compared":[164],"Fisher's":[166],"exact":[167,170],"Fisher-Freeman-Halton":[169],"tests,":[171],"continuous":[173],"independent-samples":[177],"t-test.":[178],"Results":[179],"Good":[180],"occurred":[183],"21":[185],"(35.0%)":[186],"eyes.":[187],"Younger":[188],"age,":[189],"branch":[190],"RVO,":[191],"non-ischemic":[193],"disease":[194],"outcomes":[199,247],"(p":[200,262],"=":[201,204,263],"0.001,":[202,209],"p":[203,207,222,249],"0.003,":[205],"<":[208,223,250],"respectively).":[210],"CMT":[214,252,277],"lower":[216],"good-outcome":[219],"group":[220],"(both":[221],"0.001).":[224,251],"Higher":[225],"EZ":[229],"disruption,":[230],"DRIL,":[231],"ELM":[233],"disruption":[234],"poor":[238],"outcomes,":[239],"whereas":[240,276],"bulge":[242],"(all":[248],">100":[254],"\u00b5m":[255],"not":[257,287],"0.778).":[264],"Conclusions":[265],"Several":[266],"outcome,":[275],"not.":[280],"These":[281],"findings":[282],"are":[283,305],"exploratory":[284],"do":[286],"establish":[288],"independent":[289],"predictive":[290],"value":[291],"utility.":[294],"Larger":[295],"studies":[296],"standardized":[298],"treatment,":[299],"multivariable":[300],"adjustment,":[301],"validation":[304],"needed.":[306]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-01T00:00:00"}